Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 5.99323654 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.61242381 |
3 | immunoglobulin mediated immune response (GO:0016064) | 5.38791485 |
4 | detection of other organism (GO:0098543) | 5.09991942 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.06958825 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.06958825 |
7 | modulation by symbiont of host immune response (GO:0052553) | 5.06958825 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.06958825 |
9 | modulation by symbiont of host defense response (GO:0052031) | 5.06958825 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.06958825 |
11 | response to peptidoglycan (GO:0032494) | 5.01540959 |
12 | macrophage activation involved in immune response (GO:0002281) | 4.86338205 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80532019 |
14 | detection of bacterium (GO:0016045) | 4.76346409 |
15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.74522645 |
16 | negative regulation of cell killing (GO:0031342) | 4.74522645 |
17 | negative regulation of interleukin-12 production (GO:0032695) | 4.67573908 |
18 | detection of molecule of bacterial origin (GO:0032490) | 4.65793459 |
19 | detection of external biotic stimulus (GO:0098581) | 4.55169393 |
20 | microglial cell activation (GO:0001774) | 4.51557022 |
21 | positive regulation of mast cell activation (GO:0033005) | 4.41663878 |
22 | positive regulation of mast cell degranulation (GO:0043306) | 4.23878773 |
23 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.23878773 |
24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.14436401 |
25 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.12081740 |
26 | cellular extravasation (GO:0045123) | 4.11499472 |
27 | detection of biotic stimulus (GO:0009595) | 4.10608157 |
28 | B cell mediated immunity (GO:0019724) | 4.09960660 |
29 | regulation of mast cell degranulation (GO:0043304) | 4.07333802 |
30 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.00151559 |
31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.99263677 |
32 | neutrophil activation (GO:0042119) | 3.98071071 |
33 | macrophage activation (GO:0042116) | 3.96880229 |
34 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.91272539 |
35 | myeloid cell activation involved in immune response (GO:0002275) | 3.87290284 |
36 | granulocyte activation (GO:0036230) | 3.83052764 |
37 | regulation of mast cell activation (GO:0033003) | 3.82081578 |
38 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.81188488 |
39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.79755762 |
40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.74767178 |
41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.67560846 |
42 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.53253067 |
43 | respiratory burst (GO:0045730) | 3.50649980 |
44 | regulation of leukocyte degranulation (GO:0043300) | 3.50557293 |
45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44946110 |
46 | response to host immune response (GO:0052572) | 3.44946110 |
47 | regulation of hypersensitivity (GO:0002883) | 3.40252213 |
48 | regulation of antigen processing and presentation (GO:0002577) | 3.32299243 |
49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.32098710 |
50 | regulation of tolerance induction (GO:0002643) | 3.31234244 |
51 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.28696988 |
52 | positive regulation of leukocyte degranulation (GO:0043302) | 3.27258310 |
53 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24957052 |
54 | positive regulation of antigen processing and presentation (GO:0002579) | 3.24840840 |
55 | regulation of T cell tolerance induction (GO:0002664) | 3.23330717 |
56 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.22592560 |
57 | neutrophil mediated immunity (GO:0002446) | 3.22347442 |
58 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.20972902 |
59 | T-helper 1 type immune response (GO:0042088) | 3.20699835 |
60 | response to muramyl dipeptide (GO:0032495) | 3.20673243 |
61 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.20126025 |
62 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.19995147 |
63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19893793 |
64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.18910831 |
65 | defense response to protozoan (GO:0042832) | 3.16970701 |
66 | positive regulation of type 2 immune response (GO:0002830) | 3.15522645 |
67 | leukocyte aggregation (GO:0070486) | 3.14094501 |
68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14020755 |
69 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12362382 |
70 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.12237516 |
71 | positive thymic T cell selection (GO:0045059) | 3.11196338 |
72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.10323202 |
73 | positive regulation of B cell differentiation (GO:0045579) | 3.09348238 |
74 | myeloid leukocyte mediated immunity (GO:0002444) | 3.08820434 |
75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08500874 |
76 | response to host (GO:0075136) | 3.08500874 |
77 | response to host defenses (GO:0052200) | 3.08500874 |
78 | cellular response to interferon-gamma (GO:0071346) | 3.08403414 |
79 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05422597 |
80 | type I interferon signaling pathway (GO:0060337) | 3.00827851 |
81 | cellular response to type I interferon (GO:0071357) | 3.00827851 |
82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99664365 |
83 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.98751683 |
84 | response to type I interferon (GO:0034340) | 2.97646689 |
85 | myeloid leukocyte activation (GO:0002274) | 2.94264085 |
86 | cell wall macromolecule catabolic process (GO:0016998) | 2.93661654 |
87 | leukocyte degranulation (GO:0043299) | 2.93486514 |
88 | regulation of regulated secretory pathway (GO:1903305) | 2.92773725 |
89 | positive regulation of interferon-alpha production (GO:0032727) | 2.91303583 |
90 | regulation of interferon-alpha production (GO:0032647) | 2.90218793 |
91 | response to protozoan (GO:0001562) | 2.88376132 |
92 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87969833 |
93 | B cell receptor signaling pathway (GO:0050853) | 2.84911047 |
94 | response to interferon-gamma (GO:0034341) | 2.84495957 |
95 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.83335318 |
96 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.82371366 |
97 | mast cell activation (GO:0045576) | 2.80605276 |
98 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80246449 |
99 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.79778896 |
100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.78400531 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.51663074 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.16398213 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.74805330 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.95258497 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.65906130 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.50646606 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.44402802 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.22964485 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22807491 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10655239 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.05828931 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96140628 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79908883 |
14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.74654006 |
15 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.69107157 |
16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.65055785 |
17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.61254285 |
18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.56459151 |
19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.50737307 |
20 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.44265937 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39111121 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34193433 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31482399 |
24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.28460745 |
25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23633066 |
26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10127756 |
27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09485926 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08571506 |
29 | MYB_26560356_Chip-Seq_TH2_Human | 2.05281263 |
30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03265817 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92259090 |
32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91708315 |
33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74594908 |
34 | MAF_26560356_Chip-Seq_TH1_Human | 1.73281627 |
35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.71708682 |
36 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.68931052 |
37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64677063 |
38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64428412 |
39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61809397 |
40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61282589 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 1.60428766 |
42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58872320 |
43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57276038 |
44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52078795 |
45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49391363 |
46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48646960 |
47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47303786 |
48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46690670 |
49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40276309 |
50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37253581 |
51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34152026 |
52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30547051 |
53 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29216488 |
54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28803678 |
55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28121201 |
56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25675563 |
57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25179138 |
58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21060747 |
59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20614199 |
60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20383096 |
61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20006109 |
62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19781180 |
63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19084289 |
64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18958766 |
65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17207419 |
66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15030214 |
67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14854652 |
68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11933764 |
69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11799100 |
70 | MAF_26560356_Chip-Seq_TH2_Human | 1.10012828 |
71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08551952 |
72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06359130 |
73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04759179 |
74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03836186 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02173206 |
76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99177871 |
77 | MYC_22102868_ChIP-Seq_BL_Human | 0.98892375 |
78 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97536992 |
79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95282918 |
80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90911476 |
81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90817416 |
82 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90454125 |
83 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90096701 |
84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85328874 |
85 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.84204117 |
86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82676806 |
87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80091149 |
88 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79910332 |
89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79792969 |
90 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78035572 |
91 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.77844624 |
92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76763893 |
93 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76702380 |
94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76497066 |
95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76432006 |
96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76058298 |
97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.71288119 |
98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.71132462 |
99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.69391700 |
100 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.68422149 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.40372704 |
2 | MP0001835_abnormal_antigen_presentation | 4.29768772 |
3 | MP0003303_peritoneal_inflammation | 3.59767841 |
4 | MP0003436_decreased_susceptibility_to | 3.55702803 |
5 | MP0006082_CNS_inflammation | 3.32686489 |
6 | MP0002419_abnormal_innate_immunity | 3.18008809 |
7 | MP0005671_abnormal_response_to | 3.15890823 |
8 | MP0009785_altered_susceptibility_to | 3.01458760 |
9 | MP0005025_abnormal_response_to | 2.87847826 |
10 | MP0005000_abnormal_immune_tolerance | 2.79570695 |
11 | MP0001800_abnormal_humoral_immune | 2.78450221 |
12 | MP0002148_abnormal_hypersensitivity_rea | 2.76598027 |
13 | MP0005058_abnormal_lysosome_morphology | 2.73744823 |
14 | MP0001790_abnormal_immune_system | 2.66161611 |
15 | MP0005387_immune_system_phenotype | 2.66161611 |
16 | MP0000685_abnormal_immune_system | 2.59019534 |
17 | MP0002452_abnormal_antigen_presenting | 2.56343171 |
18 | MP0002723_abnormal_immune_serum | 2.51569806 |
19 | MP0003172_abnormal_lysosome_physiology | 2.37698136 |
20 | MP0003300_gastrointestinal_ulcer | 2.33150157 |
21 | MP0002420_abnormal_adaptive_immunity | 2.31324916 |
22 | MP0001819_abnormal_immune_cell | 2.30529435 |
23 | MP0003191_abnormal_cellular_cholesterol | 2.16312730 |
24 | MP0005464_abnormal_platelet_physiology | 2.12742297 |
25 | MP0001533_abnormal_skeleton_physiology | 2.05320556 |
26 | MP0009764_decreased_sensitivity_to | 1.90064683 |
27 | MP0001845_abnormal_inflammatory_respons | 1.86310076 |
28 | MP0003828_pulmonary_edema | 1.85623659 |
29 | MP0002405_respiratory_system_inflammati | 1.72305450 |
30 | MP0010155_abnormal_intestine_physiology | 1.71403731 |
31 | MP0003075_altered_response_to | 1.69615081 |
32 | MP0000716_abnormal_immune_system | 1.66297819 |
33 | MP0008469_abnormal_protein_level | 1.62707308 |
34 | MP0003690_abnormal_glial_cell | 1.62685366 |
35 | MP0000343_altered_response_to | 1.58342119 |
36 | MP0000569_abnormal_digit_pigmentation | 1.53841319 |
37 | MP0002398_abnormal_bone_marrow | 1.53440221 |
38 | MP0009840_abnormal_foam_cell | 1.53372158 |
39 | MP0002998_abnormal_bone_remodeling | 1.50267960 |
40 | MP0000604_amyloidosis | 1.48092149 |
41 | MP0004947_skin_inflammation | 1.43093592 |
42 | MP0001853_heart_inflammation | 1.40732501 |
43 | MP0003763_abnormal_thymus_physiology | 1.39798021 |
44 | MP0009278_abnormal_bone_marrow | 1.39773460 |
45 | MP0000689_abnormal_spleen_morphology | 1.38949445 |
46 | MP0000465_gastrointestinal_hemorrhage | 1.38735377 |
47 | MP0000858_altered_metastatic_potential | 1.37074519 |
48 | MP0004883_abnormal_blood_vessel | 1.35591133 |
49 | MP0009333_abnormal_splenocyte_physiolog | 1.35325131 |
50 | MP0005397_hematopoietic_system_phenotyp | 1.35277898 |
51 | MP0001545_abnormal_hematopoietic_system | 1.35277898 |
52 | MP0003183_abnormal_peptide_metabolism | 1.34333382 |
53 | MP0002166_altered_tumor_susceptibility | 1.33857458 |
54 | MP0005310_abnormal_salivary_gland | 1.31883120 |
55 | MP0008260_abnormal_autophagy | 1.31365972 |
56 | MP0002429_abnormal_blood_cell | 1.27835069 |
57 | MP0003866_abnormal_defecation | 1.25232177 |
58 | MP0002722_abnormal_immune_system | 1.24814405 |
59 | MP0005166_decreased_susceptibility_to | 1.23790278 |
60 | MP0003806_abnormal_nucleotide_metabolis | 1.19244610 |
61 | MP0005164_abnormal_response_to | 1.15648122 |
62 | MP0005451_abnormal_body_composition | 1.12214432 |
63 | MP0008004_abnormal_stomach_pH | 1.11709681 |
64 | MP0003448_altered_tumor_morphology | 1.11039160 |
65 | MP0002277_abnormal_respiratory_mucosa | 1.08575517 |
66 | MP0001851_eye_inflammation | 1.06475031 |
67 | MP0004510_myositis | 1.03917784 |
68 | MP0009763_increased_sensitivity_to | 1.01382946 |
69 | MP0002132_abnormal_respiratory_system | 0.96961685 |
70 | MP0005167_abnormal_blood-brain_barrier | 0.95565634 |
71 | MP0000015_abnormal_ear_pigmentation | 0.93691724 |
72 | MP0000249_abnormal_blood_vessel | 0.85423399 |
73 | MP0003656_abnormal_erythrocyte_physiolo | 0.85358038 |
74 | MP0002396_abnormal_hematopoietic_system | 0.84838224 |
75 | MP0002009_preneoplasia | 0.84505630 |
76 | MP0002006_tumorigenesis | 0.83898363 |
77 | MP0001663_abnormal_digestive_system | 0.83767853 |
78 | MP0000920_abnormal_myelination | 0.83539670 |
79 | MP0000703_abnormal_thymus_morphology | 0.81972143 |
80 | MP0005360_urolithiasis | 0.80679499 |
81 | MP0005390_skeleton_phenotype | 0.78734956 |
82 | MP0005075_abnormal_melanosome_morpholog | 0.78341483 |
83 | MP0005365_abnormal_bile_salt | 0.74973449 |
84 | MP0001542_abnormal_bone_strength | 0.73659186 |
85 | MP0004381_abnormal_hair_follicle | 0.70733340 |
86 | MP0002139_abnormal_hepatobiliary_system | 0.70529781 |
87 | MP0005174_abnormal_tail_pigmentation | 0.70078438 |
88 | MP0001986_abnormal_taste_sensitivity | 0.68888409 |
89 | MP0003795_abnormal_bone_structure | 0.67700239 |
90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61626889 |
91 | MP0005319_abnormal_enzyme/_coenzyme | 0.61101720 |
92 | MP0001873_stomach_inflammation | 0.60934310 |
93 | MP0002933_joint_inflammation | 0.60283925 |
94 | MP0002138_abnormal_hepatobiliary_system | 0.60072212 |
95 | MP0000609_abnormal_liver_physiology | 0.57519811 |
96 | MP0009765_abnormal_xenobiotic_induced | 0.56597603 |
97 | MP0002332_abnormal_exercise_endurance | 0.54142733 |
98 | MP0006054_spinal_hemorrhage | 0.53873316 |
99 | MP0009115_abnormal_fat_cell | 0.53195741 |
100 | MP0003329_amyloid_beta_deposits | 0.52164042 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 6.18465538 |
2 | Recurrent abscess formation (HP:0002722) | 6.07970330 |
3 | Eczematoid dermatitis (HP:0000976) | 5.56778223 |
4 | Abnormality of macrophages (HP:0004311) | 5.32287367 |
5 | Systemic lupus erythematosus (HP:0002725) | 5.13654503 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.91571980 |
7 | Myositis (HP:0100614) | 4.77389778 |
8 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.58588330 |
9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.58588330 |
10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.58588330 |
11 | Orchitis (HP:0100796) | 4.48264612 |
12 | Retrobulbar optic neuritis (HP:0100654) | 4.36081918 |
13 | Optic neuritis (HP:0100653) | 4.36081918 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.20913008 |
15 | Recurrent skin infections (HP:0001581) | 4.10781917 |
16 | Stomatitis (HP:0010280) | 4.07785689 |
17 | Amyloidosis (HP:0011034) | 3.96025568 |
18 | Mediastinal lymphadenopathy (HP:0100721) | 3.89395721 |
19 | Spontaneous hematomas (HP:0007420) | 3.85296635 |
20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.83799529 |
21 | Obstructive lung disease (HP:0006536) | 3.83799529 |
22 | Increased cerebral lipofuscin (HP:0011813) | 3.77227895 |
23 | Recurrent fungal infections (HP:0002841) | 3.68890446 |
24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.60353705 |
25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.60353705 |
26 | Meningitis (HP:0001287) | 3.57951089 |
27 | Gingivitis (HP:0000230) | 3.48435732 |
28 | Hemoptysis (HP:0002105) | 3.30550779 |
29 | Glomerulonephritis (HP:0000099) | 3.26168426 |
30 | Pulmonary infiltrates (HP:0002113) | 3.23223158 |
31 | Dysostosis multiplex (HP:0000943) | 3.18430272 |
32 | Keratoconjunctivitis sicca (HP:0001097) | 3.15636969 |
33 | Vacuolated lymphocytes (HP:0001922) | 3.13098582 |
34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.12178192 |
35 | Vasculitis (HP:0002633) | 3.10642082 |
36 | Urticaria (HP:0001025) | 3.05656116 |
37 | Gastrointestinal infarctions (HP:0005244) | 3.03094278 |
38 | Loss of speech (HP:0002371) | 3.01658485 |
39 | Keratoconjunctivitis (HP:0001096) | 2.94631691 |
40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.93960206 |
41 | Disinhibition (HP:0000734) | 2.91941471 |
42 | Encephalitis (HP:0002383) | 2.90757562 |
43 | Complement deficiency (HP:0004431) | 2.82462149 |
44 | Chest pain (HP:0100749) | 2.73301639 |
45 | Abnormality of complement system (HP:0005339) | 2.68139284 |
46 | Pustule (HP:0200039) | 2.67742885 |
47 | Epistaxis (HP:0000421) | 2.67012553 |
48 | Pulmonary embolism (HP:0002204) | 2.66370202 |
49 | Recurrent viral infections (HP:0004429) | 2.60822585 |
50 | Gingival bleeding (HP:0000225) | 2.59765420 |
51 | Mutism (HP:0002300) | 2.59568152 |
52 | T lymphocytopenia (HP:0005403) | 2.56663009 |
53 | Purpura (HP:0000979) | 2.54044817 |
54 | Prolonged bleeding time (HP:0003010) | 2.53957324 |
55 | Arterial thrombosis (HP:0004420) | 2.49487457 |
56 | Leukocytosis (HP:0001974) | 2.47816602 |
57 | Abnormality of T cell number (HP:0011839) | 2.46576396 |
58 | Inflammation of the large intestine (HP:0002037) | 2.44299757 |
59 | Increased IgE level (HP:0003212) | 2.43938030 |
60 | Gangrene (HP:0100758) | 2.42989733 |
61 | Cellulitis (HP:0100658) | 2.39335180 |
62 | Colitis (HP:0002583) | 2.38701987 |
63 | Autoimmune thrombocytopenia (HP:0001973) | 2.38584200 |
64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37961870 |
65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37961870 |
66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37961870 |
67 | Abnormality of the pleura (HP:0002103) | 2.37380429 |
68 | Petechiae (HP:0000967) | 2.37160895 |
69 | Increased serum ferritin (HP:0003281) | 2.32355741 |
70 | Gastrointestinal inflammation (HP:0004386) | 2.28497788 |
71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27289572 |
72 | Mucopolysacchariduria (HP:0008155) | 2.27289572 |
73 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.25850178 |
74 | Episodic fever (HP:0001954) | 2.22967259 |
75 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21544851 |
76 | Abnormality of the prostate (HP:0008775) | 2.21266755 |
77 | Polyneuropathy (HP:0001271) | 2.21140657 |
78 | Abnormality of iron homeostasis (HP:0011031) | 2.20050335 |
79 | Osteomyelitis (HP:0002754) | 2.18414762 |
80 | Hematochezia (HP:0002573) | 2.12067103 |
81 | Anorexia (HP:0002039) | 2.08070096 |
82 | Premature loss of primary teeth (HP:0006323) | 2.07284002 |
83 | Periodontitis (HP:0000704) | 2.07224908 |
84 | Vertigo (HP:0002321) | 2.06442234 |
85 | Basal ganglia calcification (HP:0002135) | 2.04409781 |
86 | Glomerulopathy (HP:0100820) | 2.03916056 |
87 | Abnormality of T cells (HP:0002843) | 2.01313113 |
88 | Panhypogammaglobulinemia (HP:0003139) | 2.01106515 |
89 | Peritonitis (HP:0002586) | 1.99693737 |
90 | Nephritis (HP:0000123) | 1.99330484 |
91 | Malnutrition (HP:0004395) | 1.99004242 |
92 | Hepatosplenomegaly (HP:0001433) | 1.98400085 |
93 | Thrombophlebitis (HP:0004418) | 1.93498182 |
94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93181772 |
95 | Hypergammaglobulinemia (HP:0010702) | 1.91641977 |
96 | Abnormality of the peritoneum (HP:0002585) | 1.89322545 |
97 | Skin rash (HP:0000988) | 1.89090748 |
98 | Memory impairment (HP:0002354) | 1.89067813 |
99 | Agammaglobulinemia (HP:0004432) | 1.87715987 |
100 | Recurrent pneumonia (HP:0006532) | 1.87062095 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.87200104 |
2 | BLK | 4.53754689 |
3 | TYK2 | 3.24511147 |
4 | MAP4K1 | 2.89260887 |
5 | FES | 2.77758775 |
6 | CSK | 2.51215121 |
7 | MAP3K14 | 2.41890967 |
8 | IRAK4 | 2.40750366 |
9 | MAP2K3 | 2.36896189 |
10 | CSF1R | 2.27866047 |
11 | BMPR2 | 2.24110230 |
12 | ZAP70 | 2.06965651 |
13 | TXK | 2.06072245 |
14 | SYK | 2.02966594 |
15 | ERN1 | 2.02216356 |
16 | JAK3 | 1.93593361 |
17 | MAP3K13 | 1.86687685 |
18 | KIT | 1.86548547 |
19 | BTK | 1.85568846 |
20 | TBK1 | 1.82041041 |
21 | FGR | 1.77938420 |
22 | TGFBR2 | 1.71061121 |
23 | PRPF4B | 1.69904549 |
24 | TNK2 | 1.68227466 |
25 | MAP3K3 | 1.67841574 |
26 | IKBKE | 1.66252752 |
27 | LYN | 1.64786613 |
28 | JAK1 | 1.60019795 |
29 | HCK | 1.54722803 |
30 | GRK6 | 1.48720151 |
31 | TAOK3 | 1.48378923 |
32 | CDK19 | 1.45969713 |
33 | TEC | 1.45636657 |
34 | JAK2 | 1.40272861 |
35 | GRK7 | 1.36913158 |
36 | IKBKB | 1.34139058 |
37 | MATK | 1.25750746 |
38 | LCK | 1.24561917 |
39 | ITK | 1.23006012 |
40 | TAOK1 | 1.22507343 |
41 | MAP3K11 | 1.20574559 |
42 | MAP3K1 | 1.13044416 |
43 | YES1 | 0.95610924 |
44 | PIK3CG | 0.91613762 |
45 | PDK1 | 0.90838500 |
46 | MARK3 | 0.90445077 |
47 | CAMKK2 | 0.87315013 |
48 | EPHB1 | 0.86698121 |
49 | IRAK1 | 0.85908496 |
50 | MOS | 0.78817213 |
51 | PDPK1 | 0.77767567 |
52 | STK10 | 0.76709921 |
53 | IRAK2 | 0.75938604 |
54 | MAPK7 | 0.75049811 |
55 | CDK6 | 0.73792229 |
56 | TAOK2 | 0.73397392 |
57 | SIK3 | 0.71050899 |
58 | MAPK12 | 0.69715803 |
59 | MAP3K6 | 0.69257177 |
60 | CDC42BPA | 0.65345657 |
61 | FYN | 0.62527487 |
62 | MARK2 | 0.61579729 |
63 | IRAK3 | 0.59829368 |
64 | ACVR1B | 0.58166723 |
65 | KSR2 | 0.52562182 |
66 | MAP3K2 | 0.51325935 |
67 | ABL1 | 0.49931055 |
68 | PRKCQ | 0.49137491 |
69 | LRRK2 | 0.47957926 |
70 | MAP3K5 | 0.46543683 |
71 | FGFR3 | 0.45228712 |
72 | TRPM7 | 0.43048251 |
73 | PIM1 | 0.42392097 |
74 | HIPK2 | 0.40898029 |
75 | RPS6KL1 | 0.38534474 |
76 | RPS6KC1 | 0.38534474 |
77 | MAP2K6 | 0.38421252 |
78 | SGK3 | 0.36748818 |
79 | EGFR | 0.36666082 |
80 | CHUK | 0.36163609 |
81 | RPS6KA6 | 0.34135825 |
82 | MAP3K7 | 0.33926311 |
83 | MAPKAPK2 | 0.33686056 |
84 | PTK2B | 0.33683230 |
85 | TESK2 | 0.31055456 |
86 | CAMK1D | 0.30845503 |
87 | CAMKK1 | 0.30648308 |
88 | PRKCD | 0.30330548 |
89 | STK11 | 0.30242449 |
90 | CDK4 | 0.30184878 |
91 | EPHA3 | 0.29807871 |
92 | DYRK1B | 0.28748670 |
93 | DAPK2 | 0.28181763 |
94 | SGK2 | 0.27342070 |
95 | IGF1R | 0.25970406 |
96 | PRKD1 | 0.24690606 |
97 | MAP2K4 | 0.24072715 |
98 | MAPK4 | 0.23408460 |
99 | PRKAA2 | 0.23378562 |
100 | ADRBK2 | 0.23152711 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.28555393 |
2 | Asthma_Homo sapiens_hsa05310 | 3.64759079 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 3.50980694 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.37912120 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.35286921 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.24965737 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.75246709 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.68974134 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58037684 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.49467795 |
11 | Tuberculosis_Homo sapiens_hsa05152 | 2.34992881 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.32179222 |
13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.16167672 |
14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.09001687 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 2.02853288 |
16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86331363 |
17 | Phagosome_Homo sapiens_hsa04145 | 1.81143799 |
18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77831257 |
19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72297657 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70597235 |
21 | Lysosome_Homo sapiens_hsa04142 | 1.68269074 |
22 | Pertussis_Homo sapiens_hsa05133 | 1.61184755 |
23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58639014 |
24 | Malaria_Homo sapiens_hsa05144 | 1.54574299 |
25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50616326 |
26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50334013 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.49909728 |
28 | Legionellosis_Homo sapiens_hsa05134 | 1.46016021 |
29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45963728 |
30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37810389 |
31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31222729 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26965968 |
33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19479840 |
34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15197060 |
35 | Measles_Homo sapiens_hsa05162 | 1.13253712 |
36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12771266 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12504605 |
38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07183904 |
39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00285333 |
40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99140079 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95901982 |
42 | Salmonella infection_Homo sapiens_hsa05132 | 0.93762946 |
43 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93670351 |
44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92810810 |
45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91907664 |
46 | Platelet activation_Homo sapiens_hsa04611 | 0.91343808 |
47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87938803 |
48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84896429 |
49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84221615 |
50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83639344 |
51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72081407 |
52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70323082 |
53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64694970 |
54 | Hepatitis B_Homo sapiens_hsa05161 | 0.64602188 |
55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62113072 |
56 | Shigellosis_Homo sapiens_hsa05131 | 0.61809853 |
57 | Amoebiasis_Homo sapiens_hsa05146 | 0.58265689 |
58 | Hepatitis C_Homo sapiens_hsa05160 | 0.57920643 |
59 | Apoptosis_Homo sapiens_hsa04210 | 0.56774332 |
60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56508136 |
61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51814198 |
62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51058174 |
63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50117399 |
64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48217643 |
65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43900344 |
66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43275916 |
67 | Prion diseases_Homo sapiens_hsa05020 | 0.42765961 |
68 | Endocytosis_Homo sapiens_hsa04144 | 0.38432777 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38015039 |
70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36882336 |
71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36295299 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36179919 |
73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36038513 |
74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35706113 |
75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35502449 |
76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35129423 |
77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34281599 |
78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34198963 |
79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33147488 |
80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33027918 |
81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32733103 |
82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31548028 |
83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31079695 |
84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29652110 |
85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26393572 |
86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26366032 |
87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24326999 |
88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22749946 |
89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20431002 |
90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20359467 |
91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18779235 |
92 | Insulin resistance_Homo sapiens_hsa04931 | 0.18750796 |
93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18389314 |
94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16108611 |
95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15584731 |
96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.15105814 |
97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14806292 |
98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.14441310 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13864897 |
100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13544674 |